- to familiarize health care and pharmaceutical industry professionals with important changes in safety profile of medicinal preparations, new safety warnings as well as recommendations for prevention of pharmacotherapy complications;
- familiarize health care workers, health professionals and citizens about the health risks associated with the use of unregistered supplements.